Cargando…

CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

Platinum-based chemotherapy is the first-line treatment for small cell lung cancer (SCLC). However, due to patients developing a resistance to the drug, most experience relapse and their cancer can become untreatable. A large number of recent studies have found that platinum drug sensitivity of vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Yonglin, Qiu, Zhengang, Yao, Zifu, Lin, Anqi, Qin, Yimin, Sha, Ruizhan, Wei, Ting, Wang, Yanru, Cheng, Quan, Zhang, Jian, Luo, Peng, Shen, Weitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787262/ https://www.ncbi.nlm.nih.gov/pubmed/35087829 http://dx.doi.org/10.3389/fcell.2021.770811

Ejemplares similares

THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients
por: Yao, Zifu, et al.
Publicado: (2022)

Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer
por: Zhuo, Zewei, et al.
Publicado: (2022)

CAMSAP2 organizes a γ-tubulin-independent microtubule nucleation centre through phase separation
por: Imasaki, Tsuyoshi, et al.
Publicado: (2022)

PTRN-1, a microtubule minus end-binding CAMSAP homolog, promotes microtubule function in Caenorhabditis elegans neurons
por: Richardson, Claire E, et al.
Publicado: (2014)

The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
por: Sun, Yueqin, et al.
Publicado: (2021)

CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer
por: Cao, Yingying, et al.
Publicado: (2021)

Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLC
por: Chen, Meng-Yu, et al.
Publicado: (2022)

Breathing New Life into the Mechanisms of Platinum Resistance in Lung Adenocarcinoma
por: Gonzalez-Rajal, Alvaro, et al.
Publicado: (2020)

PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients
por: Xing, Linan, et al.
Publicado: (2021)

Identification of a Glycosyltransferase Signature for Predicting Prognosis and Immune Microenvironment in Neuroblastoma
por: Sha, Yongliang, et al.
Publicado: (2022)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

Identification of CHMP7 as a promising immunobiomarker for immunotherapy and chemotherapy and impact on prognosis of colorectal cancer patients
por: Guo, Yu, et al.
Publicado: (2023)

Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020)

CAMSAP3 maintains neuronal polarity through regulation of microtubule stability
por: Pongrakhananon, Varisa, et al.
Publicado: (2018)

Effect of AKT1 (p. E17K) Hotspot Mutation on Malignant Tumorigenesis and Prognosis
por: Chen, Ying, et al.
Publicado: (2020)

TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer
por: Zhang, Ziwen, et al.
Publicado: (2021)

TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer
por: Zhang, Feng, et al.
Publicado: (2021)

The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy
por: Li, Lianbo
Publicado: (2022)

A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2021)

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer
por: Yi, Ruibin, et al.
Publicado: (2022)

A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
por: Zhang, Kai, et al.
Publicado: (2022)

Hypermethylation of DHRS3 as a Novel Tumor Suppressor Involved in Tumor Growth and Prognosis in Gastric Cancer
por: Sumei, Sha, et al.
Publicado: (2021)

Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma
por: Qian, Hu, et al.
Publicado: (2021)

The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
por: Luo, Jiangti, et al.
Publicado: (2023)

HIF1α Regulates IL17 Signaling Pathway Influencing Sensitivity of Taxane-Based Chemotherapy for Breast Cancer
por: Dai, Huijuan, et al.
Publicado: (2021)

Highly Water-Preserving Zwitterionic Betaine-Incorporated Collagen Sponges With Anti-oxidation and Anti-inflammation for Wound Regeneration
por: Chen, Anqi, et al.
Publicado: (2020)

Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma
por: Gao, Ze, et al.
Publicado: (2021)

Mitochondrial Mutations in Ethambutol-Induced Optic Neuropathy
por: Zhang, Xiao-Hui, et al.
Publicado: (2021)

Identification of ACTA2 as a Key Contributor to Venous Malformation
por: Wang, Song, et al.
Publicado: (2021)

The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy
por: Liu, Jiazhou, et al.
Publicado: (2022)

α-Enolase Lies Downstream of mTOR/HIF1α and Promotes Thyroid Carcinoma Progression by Regulating CST1
por: Liu, Yang, et al.
Publicado: (2021)

A Novel TCGA-Validated, MiRNA-Based Signature for Prediction of Breast Cancer Prognosis and Survival
por: Tian, Baoxing, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

Reveal the Regulation Patterns of Prognosis-Related miRNAs and lncRNAs Across Solid Tumors in the Cancer Genome Atlas
por: Yin, Zuojing, et al.
Publicado: (2020)

A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer
por: Ping, Liqin, et al.
Publicado: (2021)

Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy
por: Ma, Yuan, et al.
Publicado: (2021)

Chemokine CCL17 Affects Local Immune Infiltration Characteristics and Early Prognosis Value of Lung Adenocarcinoma
por: Ye, Ting, et al.
Publicado: (2022)

The Role of m6A RNA Methylation-Related lncRNAs in the Prognosis and Tumor Immune Microenvironment of Papillary Thyroid Carcinoma
por: Wang, Wenlong, et al.
Publicado: (2022)

Integrated Characterization of lncRNA-Immune Interactions in Prostate Cancer
por: Hu, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1lrdln32tte0o6v7c2ct8sbhfd